1. Home
  2. STIM vs MRCC Comparison

STIM vs MRCC Comparison

Compare STIM & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$2.02

Market Cap

95.6M

Sector

Health Care

ML Signal

HOLD

Logo Monroe Capital Corporation

MRCC

Monroe Capital Corporation

HOLD

Current Price

$5.08

Market Cap

100.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STIM
MRCC
Founded
2003
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
95.6M
100.1M
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
STIM
MRCC
Price
$2.02
$5.08
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
1.8M
153.9K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
7.09%
EPS Growth
57.25
N/A
EPS
N/A
N/A
Revenue
$52,776,000.00
N/A
Revenue This Year
$11.10
N/A
Revenue Next Year
$11.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$4.11
52 Week High
$4.84
$7.76

Technical Indicators

Market Signals
Indicator
STIM
MRCC
Relative Strength Index (RSI) 69.40 52.95
Support Level $1.23 $4.44
Resistance Level $2.13 $6.77
Average True Range (ATR) 0.14 0.24
MACD 0.05 0.09
Stochastic Oscillator 84.90 71.19

Price Performance

Historical Comparison
STIM
MRCC

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

About MRCC Monroe Capital Corporation

Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the United States and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants. Its investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through investment in senior secured, unitranche secured and junior secured debt and, to a lesser extent, unsecured subordinated debt and equity investments.

Share on Social Networks: